眼科 ›› 2024, Vol. 33 ›› Issue (5): 329-336.doi: 10.13281/j.cnki.issn.1004-4469.2024.05.002

• 论著 • 上一篇    下一篇

湖南省青光眼患者的诊疗现况及疾病负担调查

张新月1,2,5   陈家玮1,2   罗君3   廖圣4   吴平1,2   廖礼1,2    段宣初1,2,5   

  1. 1 长沙爱尔眼科医院,长沙410000;2 中南大学爱尔眼科研究院,长沙410000;3 衡阳爱尔眼科医院,湖南衡阳421000;4 娄底爱尔眼科医院,湖南娄底417000;5 长沙爱尔眼科医院青光眼研究所 湖南省青光眼智能辅助诊断与新材料应用工程技术研究中心,长沙410000
  • 收稿日期:2024-05-15 出版日期:2024-09-25 发布日期:2024-08-28
  • 通讯作者: 段宣初,Email: duanxchu@csu.edu.cn
  • 基金资助:
    湖南省青光眼智能辅助诊断与新材料应用工程技术研究中心(2023TP2225);湖南省自然科学基金(2023JJ 70014);长沙市自然科学基金(kq2208495);爱尔眼科医院集团科研基金(AR2206D5)

Investigation on the diagnosis and treatment status and disease burden of glaucoma patients in Hunan Province

Zhang Xinyue1, 2, 5, Chen Jiawei1, 2, Luo Jun3, Liao Sheng4, Wu Ping1, 2, Liao Li1, 2, Duan Xuanchu1, 2, 5   

  1. 1 Changsha Aier Eye Hospital, Changsha 410000, China; 2 Aier Academy of Ophthalmology, Central South University, Changsha 410000, China; 3 Hengyang Aier Eye Hospital, Hengyang Hunan 421000, China; 4 Loudi Aier Eye Hospital, Loudi Hunan 417000,  China; 5 Aier Glaucoma Institute, Hunan Engineering Research Center for Glaucoma with Artificial Intelligence in Diagnosis and Application of New Materials, Changsha Aier Eye Hospital, Changsha 410000, China
  • Received:2024-05-15 Online:2024-09-25 Published:2024-08-28
  • Contact: Duan Xuanchu, Email: duanxchu@csu.edu.cn
  • Supported by:
    Hunan Engineering Research Center for Glaucoma with Artificial Intelligence in Diagnosis and Application of New Materials (2023TP2225); Natural Science Foundation of Hunan Province, China (2023JJ70014); Changsha Municipal Natural Science Foundation (kq2208495); Science and Technology Foundation of Aier Eye Hospital Group, China (AR2206D5)

摘要:  目的 调查湖南省青光眼患者的诊疗现况、依从性、生活质量及疾病负担。设计 问卷调查。研究对象 2023年12月25日至2024年1月31日就诊于长沙爱尔眼科医院、衡阳爱尔眼科医院和娄底爱尔眼科医院青光眼科门诊的243例青光眼患者。方法 采用2022年《青光眼综合防治管理蓝皮书》调研项目的调查问卷,以线上问卷方式进行单纯随机抽样调查,问卷内容包括人口学信息、患者诊疗综合管理、患者依从性和生活质量、疾病负担。主要指标 患者诊疗现况的统计描述、用药依从性评分、生活质量评分、视力和视野的损伤程度构成比。结果 85.2%的患者在三级医院确诊青光眼,晚期视野损伤的患者目标眼压达标率56.5%~57.1%。95.9%的青光眼患者通过医院就诊面对面咨询医生获取青光眼相关知识,79.4%的患者希望获得健康宣教和74.1%希望获得青光眼筛查服务。31.3%的青光眼患者为低用药依从性,主要影响因素为忘记用药(89.5%)。青光眼患者的平均生活质量评分为58.4±9.3(得分比68.7%),不同治疗方案的患者生活质量评分具有统计学差异(F=4.947,P<0.001),其中仅行激光治疗的患者生活质量评分最高(70.2±10.6)。72.0%的青光眼患者有不同程度的视力损伤,67.5%的患者有不同程度的视野损伤,27.2%的患者至少一眼为盲,不同类型青光眼患者的视野损伤程度存在统计学差异(χ2=11.099,P=0.011),其中原发性开角型青光眼患者的视野损伤比例最高(78.6%)。结论 湖南省青光眼患者的用药依从性不高、生活质量偏低,缺乏青光眼知识、获取青光眼知识途径单一,视觉损伤比例高,致盲率高。需针对本区域青光眼患者特点加强青光眼患者管理,降低致盲率。(眼科,2024, 33:329-336

关键词: 青光眼, 诊疗现况, 用药依从性, 生活质量, 疾病负担

Abstract:  Objective To investigate the diagnosis and treatment status, compliance, quality of life and disease burden of glaucoma patients in Hunan Province. Design Questionnaire research. Participants A total of 243 glaucoma outpatients were recruited from the glaucoma clinic of Changsha Aier Eye Hospital, Hengyang Aier Eye Hospital, and Loudi Aier Eye Hospital in Hunan Province from December 25, 2023 to January 31, 2024. Methods The questionnaire from the Blue Book on Comprehensive Prevention and Treatment Management of Glaucoma was used to conduct a simple random sampling survey in the form of an online questionnaire. The questionnaire included the content of demographic information, comprehensive diagnosis and treatment management, patient adherence and quality of life, and disease burden. Main Outcome Measures Statistical description of the patient's diagnosis and treatment status, medication adherence score, quality of life score, and the proportion of visual acuity and visual field impairment. Results Totally, 85.2% of glaucoma patients were diagnosed with glaucoma in tertiary hospitals. 56.5%~57.1% of patients with late-stage visual field damage achieved their target intraocular pressure. 95.9% of glaucoma patients acquired glaucoma knowledge through face-to-face consultation with doctors during hospital visits. 79.4% of patients hoped to receive health education and 74.1% hoped to receive glaucoma screening services. 31.3% of glaucoma patients had a low medication adherence, with the possible factor of forgetting to use eye drops (89.5%). The average quality-of-life score of glaucoma patients was 58.4±9.3 (score ratio: 68.7%), and a significant difference was found inquality-of-life score of patients achieved different treatments (F=4.947, P<0.001). Among them, patients who only received laser treatment had the highest quality of life score, which was 70.2±10.6. Respectively, 72.0% and 67.5% of glaucoma patients had visual impairment and visual field damage on at least one of eyes. 27.2% of glaucoma patients had at least one blind eye, and there was significant difference in visual field damage among different types of glaucoma patients (χ2=11.099, P=0.011). Among them, patients with primary open-angle glaucoma had the highest proportion of visual field damage (78.6%). Conclusions In Hunan Province, glaucoma patients had low education level, medication compliance, and quality of life. They lacked knowledge about glaucoma and ways to acquire glaucoma knowledge. They had a high proportion of visual impairment and blindness. In order to reduce the rate of blindness caused by glaucoma, it is necessary to strengthen the management of glaucoma patients according to the characteristics of glaucoma patients in this region. (Ophthalmol CHN, 2024, 33: 329-336)

Key words: glaucoma, diagnosis and treatment, medication adherence, quality of life, disease burden